«Identifying specific biomarkers of latently infected cells is considered as the «holy grail» in the HIV eradication field,» said lead corresponding author Luis J. Montaner, D.V.M., D.Phil., director of the HIV - 1
Immunopathogenesis Unit at The Wistar Institute Vaccine & Immunotherapy Center.